发布求助
文献互助 智能选刊 最新文献

Medical Letter on Drugs and Therapeutics最新文献

筛选
英文 中文
Seladelpar (Livdelzi) for primary biliary cholangitis. Seladelpar （Livdelzi）治疗原发性胆管炎。
IF 1.4 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2025-01-20 DOI: 10.58347/tml.2025.1720d
{"title":"Seladelpar (Livdelzi) for primary biliary cholangitis.","authors":"","doi":"10.58347/tml.2025.1720d","DOIUrl":"https://doi.org/10.58347/tml.2025.1720d","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":"67 1720","pages":"13-15"},"PeriodicalIF":1.4,"publicationDate":"2025-01-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143016870","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Emrosi - low-dose, biphasic oral minocycline for rosacea. Emrosi -低剂量，双相口服米诺环素治疗酒渣鼻。
IF 1.4 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2025-01-20 DOI: 10.58347/tml.2025.1720b
{"title":"Emrosi - low-dose, biphasic oral minocycline for rosacea.","authors":"","doi":"10.58347/tml.2025.1720b","DOIUrl":"https://doi.org/10.58347/tml.2025.1720b","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":"67 1720","pages":"10-11"},"PeriodicalIF":1.4,"publicationDate":"2025-01-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143016867","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Zanidatamab (Ziihera) for biliary tract cancer. Zanidatamab （Ziihera）用于胆道癌。
IF 1.4 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2025-01-20 DOI: 10.58347/tml.2025.1720df
{"title":"Zanidatamab (Ziihera) for biliary tract cancer.","authors":"","doi":"10.58347/tml.2025.1720df","DOIUrl":"https://doi.org/10.58347/tml.2025.1720df","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":"67 1720","pages":"e16-e17"},"PeriodicalIF":1.4,"publicationDate":"2025-01-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143016879","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Zenocutuzumab (Bizengri) for NSCLC and pancreatic adenocarcinoma. Zenocutuzumab （Bizengri）用于非小细胞肺癌和胰腺腺癌。
IF 1.4 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2025-01-20 DOI: 10.58347/tml.2025.1720e
{"title":"Zenocutuzumab (Bizengri) for NSCLC and pancreatic adenocarcinoma.","authors":"","doi":"10.58347/tml.2025.1720e","DOIUrl":"https://doi.org/10.58347/tml.2025.1720e","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":"67 1720","pages":"15-16"},"PeriodicalIF":1.4,"publicationDate":"2025-01-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143016882","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dupilumab (Dupixent) for COPD. Dupilumab （Dupixent）治疗COPD。
IF 1.4 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2025-01-20 DOI: 10.58347/tml.2025.1720c
{"title":"Dupilumab (Dupixent) for COPD.","authors":"","doi":"10.58347/tml.2025.1720c","DOIUrl":"https://doi.org/10.58347/tml.2025.1720c","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":"67 1720","pages":"11-13"},"PeriodicalIF":1.4,"publicationDate":"2025-01-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143016866","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Valeda Light Delivery System for age-related macular degeneration. Valeda光传送系统治疗老年性黄斑变性。
IF 1.4 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2025-01-20 DOI: 10.58347/tml.2025.1720a
{"title":"Valeda Light Delivery System for age-related macular degeneration.","authors":"","doi":"10.58347/tml.2025.1720a","DOIUrl":"https://doi.org/10.58347/tml.2025.1720a","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":"67 1720","pages":"9-10"},"PeriodicalIF":1.4,"publicationDate":"2025-01-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143016872","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Drugs for age-related macular degeneration. 治疗年龄相关性黄斑变性的药物。
IF 1.4 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2025-01-06 DOI: 10.58347/tml.2025.1719a
{"title":"Drugs for age-related macular degeneration.","authors":"","doi":"10.58347/tml.2025.1719a","DOIUrl":"https://doi.org/10.58347/tml.2025.1719a","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":"67 1719","pages":"1-5"},"PeriodicalIF":1.4,"publicationDate":"2025-01-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142958977","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vyalev - foscarbidopa/foslevodopa subcutaneous infusion for Parkinson's disease. Vyalev - foscarbidopa/foslevodopa皮下输注治疗帕金森病。
IF 1.4 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2025-01-06 DOI: 10.58347/tml.2025.1719c
{"title":"Vyalev - foscarbidopa/foslevodopa subcutaneous infusion for Parkinson's disease.","authors":"","doi":"10.58347/tml.2025.1719c","DOIUrl":"https://doi.org/10.58347/tml.2025.1719c","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":"67 1719","pages":"7-8"},"PeriodicalIF":1.4,"publicationDate":"2025-01-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142958983","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Qlosi - pilocarpine 0.4% ophthalmic solution for presbyopia. Qlosi -匹罗卡品0.4%老花眼液。
IF 1.4 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2025-01-06 DOI: 10.58347/tml.2025.1719b
{"title":"Qlosi - pilocarpine 0.4% ophthalmic solution for presbyopia.","authors":"","doi":"10.58347/tml.2025.1719b","DOIUrl":"https://doi.org/10.58347/tml.2025.1719b","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":"67 1719","pages":"5-6"},"PeriodicalIF":1.4,"publicationDate":"2025-01-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142958979","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Revumenib (Revuforj) for acute leukemia. Revumenib （Revuforj）治疗急性白血病。
IF 1.4 4区 医学
Medical Letter on Drugs and Therapeutics Pub Date : 2025-01-06 DOI: 10.58347/tml.2025.1719d
{"title":"Revumenib (Revuforj) for acute leukemia.","authors":"","doi":"10.58347/tml.2025.1719d","DOIUrl":"https://doi.org/10.58347/tml.2025.1719d","url":null,"abstract":"","PeriodicalId":54742,"journal":{"name":"Medical Letter on Drugs and Therapeutics","volume":"67 1719","pages":"e8-e9"},"PeriodicalIF":1.4,"publicationDate":"2025-01-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142958980","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信